332 related articles for article (PubMed ID: 25831915)
1. Emotional stress as a cause of syncope and torsade de pointes in patients with long QT syndrome.
Vukmirović M; Vukmirović IT; Angelkov L; Vukmirović F
Vojnosanit Pregl; 2015 Feb; 72(2):192-5. PubMed ID: 25831915
[TBL] [Abstract][Full Text] [Related]
2. Unique ECG presentations and clinical management of a symptomatic LQT2 female carrying a novel de novo KCNH2 mutation.
Yin C; Zhang P; Yang J; Zhang L
J Electrocardiol; 2018; 51(1):111-116. PubMed ID: 29037423
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous onset of torsade de pointes in long-QT syndrome and the role of sympathovagal imbalance.
Fujiki A; Nishida K; Mizumaki K; Nagasawa H; Shimono M; Inoue H
Jpn Circ J; 2001 Dec; 65(12):1087-90. PubMed ID: 11768004
[TBL] [Abstract][Full Text] [Related]
4. Acquired long QT syndrome from stress cardiomyopathy is associated with ventricular arrhythmias and torsades de pointes.
Madias C; Fitzgibbons TP; Alsheikh-Ali AA; Bouchard JL; Kalsmith B; Garlitski AC; Tighe DA; Estes NA; Aurigemma GP; Link MS
Heart Rhythm; 2011 Apr; 8(4):555-61. PubMed ID: 21146632
[TBL] [Abstract][Full Text] [Related]
5. A case of short QT-interval postventricular arrhythmia arrest from Torsade De Pointes, a new phenotype, or the result of tachycardia-mediated imbalance.
Ifedili I; Maturana M; Kayali S; Levine Y; Kabra R; Jha SK
J Cardiovasc Electrophysiol; 2024 Mar; 35(3):501-504. PubMed ID: 38174843
[TBL] [Abstract][Full Text] [Related]
6. Congenital long QT syndrome: severe torsades de pointes provoked by epinephrine in a digenic mutation carrier.
Tan VH; Duff H; Kuriachan V; Gerull B
Heart Lung; 2014; 43(6):541-5. PubMed ID: 25236808
[TBL] [Abstract][Full Text] [Related]
7. Pause-dependent torsade de pointes following acute myocardial infarction: a variant of the acquired long QT syndrome.
Halkin A; Roth A; Lurie I; Fish R; Belhassen B; Viskin S
J Am Coll Cardiol; 2001 Oct; 38(4):1168-74. PubMed ID: 11583899
[TBL] [Abstract][Full Text] [Related]
8. Predicting torsade de pointes in acquired long QT syndrome: optimal identification of critical QT interval prolongation.
Chiladakis J; Kalogeropoulos A; Zagkli F; Koutsogiannis N; Chouchoulis K; Alexopoulos D
Cardiology; 2012; 122(1):3-11. PubMed ID: 22626988
[TBL] [Abstract][Full Text] [Related]
9. Mexiletine effectively prevented refractory Torsades de Pointes and ventricular fibrillation in a patient with congenital type 2 long QT syndrome.
Nakashima R; Takase S; Kai K; Sakamoto K; Tsutsui H
J Cardiovasc Electrophysiol; 2022 Jul; 33(7):1592-1595. PubMed ID: 35488741
[TBL] [Abstract][Full Text] [Related]
10. Premature atrial contractions with multiple patterns of aberrant conduction followed by torsade de pointes in a patient with polymyalgia rheumatica: A case report.
Takahashi K; Yamashita M; Sakaue T; Enomoto D; Uemura S; Okura T; Ikeda S; Takemoto M; Utsunomiya Y; Hyodo T; Ochi M; Higuchi S
Medicine (Baltimore); 2021 Sep; 100(37):e27286. PubMed ID: 34664888
[TBL] [Abstract][Full Text] [Related]
11. Evaluation and Management of Athletes With Long QT Syndrome.
Gomez AT; Prutkin JM; Rao AL
Sports Health; 2016; 8(6):527-535. PubMed ID: 27480102
[TBL] [Abstract][Full Text] [Related]
12. [Acquired long QT syndrome with torsade de pointes in a patient with primary hypothyroidism].
Kukla P; Szczuka K; Słowiak-Lewińska T; Bromblik A; Hajduk B; Kluczewski M; Lenard B; Przewor M
Kardiol Pol; 2003 Mar; 58(3):224-6. PubMed ID: 14513098
[TBL] [Abstract][Full Text] [Related]
13. Long QT syndrome and short QT syndrome.
Zareba W; Cygankiewicz I
Prog Cardiovasc Dis; 2008; 51(3):264-78. PubMed ID: 19026859
[TBL] [Abstract][Full Text] [Related]
14. Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study.
Salem JE; Bretagne M; Lebrun-Vignes B; Waintraub X; Gandjbakhch E; Hidden-Lucet F; Gougis P; Bachelot A; Funck-Brentano C;
Arch Cardiovasc Dis; 2019 Nov; 112(11):699-712. PubMed ID: 31477476
[TBL] [Abstract][Full Text] [Related]
15. Mode of onset of torsade de pointes in congenital long QT syndrome.
Viskin S; Alla SR; Barron HV; Heller K; Saxon L; Kitzis I; Hare GF; Wong MJ; Lesh MD; Scheinman MM
J Am Coll Cardiol; 1996 Nov; 28(5):1262-8. PubMed ID: 8890825
[TBL] [Abstract][Full Text] [Related]
16. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
Lu HR; Yan GX; Gallacher DJ
J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
[TBL] [Abstract][Full Text] [Related]
17. Auditory stimuli as a major cause of syncope in a patient with idiopathic long QT syndrome.
Nakajima T; Misu K; Iwasawa K; Tamiya E; Segawa K; Matsuo H; Hada K
Jpn Circ J; 1995 Apr; 59(4):241-6. PubMed ID: 7658619
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors of ventricular fibrillation triggered by pause-dependent torsades de pointes associated with acquired long QT interval: role of QT dispersion and left ventricular function.
Da Costa A; Chalvidan T; Belounas A; Messier M; Viallet M; Mansour H; Lamaison D; Djiane P; Isaaz K
J Cardiovasc Electrophysiol; 2000 Sep; 11(9):990-7. PubMed ID: 11021469
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.
Haddad PM; Anderson IM
Drugs; 2002; 62(11):1649-71. PubMed ID: 12109926
[TBL] [Abstract][Full Text] [Related]
20. Polymorphic ventricular tachycardia, ischaemic ventricular fibrillation, and torsade de pointes: importance of the QT and the coupling interval in the differential diagnosis.
Rosso R; Hochstadt A; Viskin D; Chorin E; Schwartz AL; Tovia-Brodie O; Laish-Farkash A; Havakuk O; Gepstein L; Banai S; Viskin S
Eur Heart J; 2021 Oct; 42(38):3965-3975. PubMed ID: 33693589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
